Browse by Topic

HIV-Age

The question addressed by this report is whether the frequency of multimorbidity (MM) is increasing over time as persons with HIV continue to age. A large cohort of adults with HIV (22,969) gathered from various sites in the US under the auspices of NA-ACCORD (North American AIDS Cohort Collaboration on Research and Design) was used to investigate the cross sectional frequencies of MM by year from 2000 to 2009. Most of the participants in this study were white men with a baseline age of 40 years.

An important question is the effect of unmet basic needs, such as food security and stable housing, on persons with HIV. A study to address this question is reported using a cohort of 496 adults with HIV living in Ontario, Canada. Needs were determined by questions, such as: In the last 12 months have you experienced difficulty in buying enough food? and How difficult is it for you to meet monthly housing costs? The outcome variables were derived from the Medical Outcomes Study HIV Health Survey and measured physical health and mental health.

With better HIV treatment, the frequency of Herpes Zoster (HZ) in older adults with HIV has dropped but is still at least two to three times higher than in persons uninfected with HIV. Also, this subgroup is still vulnerable for complications when infected with HZ. So, many clinicians recommend use of the vaccine in HIV-positive adults 50 and older with an undetectable viral load and a CD4 count over 200. A study at 6 sites was implemented to determine the level of vaccine use at baseline and the effect of two regimens for improvement.

There is variability in reports about the presence of an increased frequency of diabetes mellitus (DM) in older persons with HIV. Most suggest an excess than in a comparison group, but the reasons for this increase are unclear. To address this issue, a longitudinal study of adults 50 years or older with HIV was mounted using data from a clinic in Vancouver, Canada. Data from 1065 patients were identified without DM who had a median of 13 years of follow-up. The onset of DM was identified from medical records using standard diagnostic criteria.

The latest (2016) HIV frequency estimate from CDC indicates that two thirds of infections have involved male-to-male sexual contact. From 2008 to 2016 the annual number of new cases in men who have sex with men (MSM) increased 3% per year in those 13-29 years (total of 106,258) and was stable for those 50 years and older (total of 29,034). Diagnoses did increase among Asians and Hispanic Latinos in the older subgroup. Blacks accounted for 25% of the diagnoses in the older group.

The FDA approved PrEP (tenofovir and emtricitabine) as a once a day single pill in 2012. Since 2014 the CDC has recommended this form of PrEP because it was found to be safe and very effective in the prevention of HIV in high-risk populations. The authors of this editorial review the realities of the current epidemic, address reasons for the underuse of this method and make suggestions for improvement.

Aging

The question addressed by this report is whether the frequency of multimorbidity (MM) is increasing over time as persons with HIV continue to age. A large cohort of adults with HIV (22,969) gathered from various sites in the US under the auspices of NA-ACCORD (North American AIDS Cohort Collaboration on Research and Design) was used to investigate the cross sectional frequencies of MM by year from 2000 to 2009. Most of the participants in this study were white men with a baseline age of 40 years.

An important question is the effect of unmet basic needs, such as food security and stable housing, on persons with HIV. A study to address this question is reported using a cohort of 496 adults with HIV living in Ontario, Canada. Needs were determined by questions, such as: In the last 12 months have you experienced difficulty in buying enough food? and How difficult is it for you to meet monthly housing costs? The outcome variables were derived from the Medical Outcomes Study HIV Health Survey and measured physical health and mental health.

With better HIV treatment, the frequency of Herpes Zoster (HZ) in older adults with HIV has dropped but is still at least two to three times higher than in persons uninfected with HIV. Also, this subgroup is still vulnerable for complications when infected with HZ. So, many clinicians recommend use of the vaccine in HIV-positive adults 50 and older with an undetectable viral load and a CD4 count over 200. A study at 6 sites was implemented to determine the level of vaccine use at baseline and the effect of two regimens for improvement.

There is variability in reports about the presence of an increased frequency of diabetes mellitus (DM) in older persons with HIV. Most suggest an excess than in a comparison group, but the reasons for this increase are unclear. To address this issue, a longitudinal study of adults 50 years or older with HIV was mounted using data from a clinic in Vancouver, Canada. Data from 1065 patients were identified without DM who had a median of 13 years of follow-up. The onset of DM was identified from medical records using standard diagnostic criteria.

The latest (2016) HIV frequency estimate from CDC indicates that two thirds of infections have involved male-to-male sexual contact. From 2008 to 2016 the annual number of new cases in men who have sex with men (MSM) increased 3% per year in those 13-29 years (total of 106,258) and was stable for those 50 years and older (total of 29,034). Diagnoses did increase among Asians and Hispanic Latinos in the older subgroup. Blacks accounted for 25% of the diagnoses in the older group.

Multimorbidity

The question addressed by this report is whether the frequency of multimorbidity (MM) is increasing over time as persons with HIV continue to age. A large cohort of adults with HIV (22,969) gathered from various sites in the US under the auspices of NA-ACCORD (North American AIDS Cohort Collaboration on Research and Design) was used to investigate the cross sectional frequencies of MM by year from 2000 to 2009. Most of the participants in this study were white men with a baseline age of 40 years.

Herpes Zoster

With better HIV treatment, the frequency of Herpes Zoster (HZ) in older adults with HIV has dropped but is still at least two to three times higher than in persons uninfected with HIV. Also, this subgroup is still vulnerable for complications when infected with HZ. So, many clinicians recommend use of the vaccine in HIV-positive adults 50 and older with an undetectable viral load and a CD4 count over 200. A study at 6 sites was implemented to determine the level of vaccine use at baseline and the effect of two regimens for improvement.

Vaccinations

With better HIV treatment, the frequency of Herpes Zoster (HZ) in older adults with HIV has dropped but is still at least two to three times higher than in persons uninfected with HIV. Also, this subgroup is still vulnerable for complications when infected with HZ. So, many clinicians recommend use of the vaccine in HIV-positive adults 50 and older with an undetectable viral load and a CD4 count over 200. A study at 6 sites was implemented to determine the level of vaccine use at baseline and the effect of two regimens for improvement.

MSM

The latest (2016) HIV frequency estimate from CDC indicates that two thirds of infections have involved male-to-male sexual contact. From 2008 to 2016 the annual number of new cases in men who have sex with men (MSM) increased 3% per year in those 13-29 years (total of 106,258) and was stable for those 50 years and older (total of 29,034). Diagnoses did increase among Asians and Hispanic Latinos in the older subgroup. Blacks accounted for 25% of the diagnoses in the older group.

Pages

Connect

Phone: 202-659-0699
Fax: 202-659-0976

Contact

AAHIVM National Office
1705 DeSales Street NW, Suite 700
Washington, D.C. 20036

About

The American Academy of HIV Medicine is a professional organization that supports the HIV practitioner and promotes accessible, quality care for all Americans living with HIV disease. Our membership of HIV practitioners and credentialed HIV Specialists™, HIV Experts™, and HIV Pharmacists™ provide direct care to the majority of HIV patients in the US.